Newleos Therapeutics
Boston, US · Founded 2024 · Delaware corporation · 3 known investors
Biotech
Founders & leadership
DD
David DonabedianExecutive Officer, Director
RH
Robert HadfieldExecutive Officer
JM
John McCabeExecutive Officer
CW
Christoph WestphalDirector
MC
Ming CheahDirector
RC
Raymond CamahortDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$93.4MraisedFeb 2025 · 11 investors · BiotechnologyRule 506(b)
▶$93.4MraisedFeb 2025 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David DonabedianExecutive Officer, Director
- Robert HadfieldExecutive Officer
- Christoph WestphalDirector
- Ming CheahDirector
- Raymond CamahortDirector
- John McCabeExecutive Officer
- Offering amount
- $93.4M
- Amount sold
- $93.4M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.